Cellectis S.A. (CLLS)
NASDAQ: CLLS · Real-Time Price · USD
3.420
+0.090 (2.70%)
At close: Mar 13, 2026, 4:00 PM EDT
3.480
+0.060 (1.75%)
After-hours: Mar 13, 2026, 4:04 PM EDT
Cellectis Stock Forecast
Stock Price Forecast
The 2 analysts that cover Cellectis stock have a consensus rating of "Strong Buy" and an average price target of $8.50, which forecasts a 148.54% increase in the stock price over the next year. The lowest target is $8.00 and the highest is $9.00.
Price Target: $8.50 (+148.54%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Dec 23, 2025.
Analyst Ratings
The average analyst rating for Cellectis stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Clear Street | Clear Street | Strong Buy Initiates $9 | Strong Buy | Initiates | $9 | +163.16% | Dec 23, 2025 |
| Barclays | Barclays | Buy Maintains $4 → $8 | Buy | Maintains | $4 → $8 | +133.92% | Oct 17, 2025 |
| Barclays | Barclays | Buy Maintains $5 → $4 | Buy | Maintains | $5 → $4 | +16.96% | May 13, 2025 |
| Barclays | Barclays | Buy Maintains $7 → $5 | Buy | Maintains | $7 → $5 | +46.20% | Nov 5, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $11 → $10 | Buy | Maintains | $11 → $10 | +192.40% | Jun 12, 2024 |
Financial Forecast
Revenue This Year
69.09M
from 49.22M
Increased by 40.37%
Revenue Next Year
63.75M
from 69.09M
Decreased by -7.73%
EPS This Year
-0.94
from -0.41
EPS Next Year
-1.18
from -0.94
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 87.0M | 92.7M | ||||
| Avg | 69.1M | 63.7M | ||||
| Low | 39.2M | 29.4M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 76.9% | 34.1% | ||||
| Avg | 40.4% | -7.7% | ||||
| Low | -20.4% | -57.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.66 | -0.90 | |
| Avg | -0.94 | -1.18 | |
| Low | -1.46 | -1.59 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.